MBOT
Microbot Medical Inc.Company Information
- Company Name
- Microbot Medical Inc.
- CIK
- CIK0000883975
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- MBOT: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- MBOT
SEC filing data through
Insider Sentiment
- Last purchase
- 2019-01-14
- Last sale
- 2020-10-19
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 100,000
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 11,385,738
- Shares outstanding
- 67,163,613
- Ownership
- 16.95%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -14.29%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 4 | 4 | 7 | 4 | 3 | 3 | 0 | 2 | 1 | 2 | 1 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 72 | 77 | 80 | 81 | 33 | 31 | 6 | 5 | 7 | 7 | 8 | 8 | ||||||
| Marketable Securities Current | 64 | 69 | 75 | 73 | 29 | 27 | 2 | 4 | 4 | 5 | 4 | 7 | ||||||
| Restricted Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | - | - | - | - | - | - | - | - | - | - | 1 | - | ||||||
| Deposits Assets Current | 1 | 1 | - | - | - | - | - | - | - | - | - | - | ||||||
| Accounts Receivable Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Inventory Net | 3 | 2 | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Deposit Assets | - | - | 1 | - | - | - | - | - | - | - | - | - | ||||||
| Deposits Assets Noncurrent | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Trade Current | - | - | - | - | - | - | 0 | - | - | - | 0 | - | ||||||
| Assets | 73 | 78 | 82 | 82 | 33 | 31 | 6 | 5 | 7 | 7 | 8 | 9 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 4 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Litigation Reserve Current | - | - | - | - | - | - | - | - | - | - | 2 | - | ||||||
| Accrued Liabilities Current | 3 | 2 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 4 | 4 | 4 | 4 | 3 | 2 | 3 | 1 | 1 | 1 | 4 | 2 | ||||||
| Common Stock Value | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 182 | 181 | 181 | 178 | 127 | 122 | 94 | 91 | 90 | 88 | 84 | 84 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 69 | 74 | 78 | 78 | 30 | 29 | 4 | 4 | 6 | 6 | 5 | 7 | ||||||
| Retained Earnings Accumulated Deficit | -113 | -108 | -104 | -101 | -97 | -94 | -91 | -88 | -84 | -82 | -80 | -76 | ||||||
| Liabilities And Stockholders Equity | 73 | 78 | 82 | 82 | 33 | 31 | 6 | 5 | 7 | 7 | 8 | 9 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 120 | 120 | 120 | 120 | 120 | 60 | 60 | 60 | 60 | 60 | 60 | 60 | ||||||
| Common Stock Shares Issued | 67 | 67 | 67 | 66 | 38 | 35 | 19 | 17 | 16 | 14 | 12 | 12 | ||||||
| Shares Outstanding | 67 | 67 | 67 | 66 | 38 | 35 | 19 | 17 | 16 | 14 | 12 | 12 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMicrobot Medical Inc. (MBOT) — SEC Financial Statements & Analysis
Microbot Medical Inc. (MBOT) is a surgical & medical instruments & apparatus company, incorporated in DE. Microbot Medical Inc. trades on Nasdaq as: MBOT. Microbot Medical Inc. (MBOT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Microbot Medical Inc. carries a market cap of $130.97M, a P/E ratio of -8.02x, a P/B ratio of 1.90x, a P/S ratio of 378.52x, an enterprise value of $127.55M, and an EV/EBITDA multiple of -6.91x. On profitability, it posts an operating margin of -5348.84%, a net margin of -4722.25%, a Return on Equity (ROE) of -32.91%, a Return on Assets (ROA) of -30.68%, and a Return on Invested Capital (ROIC) of -40.35%. Per share, it reports EPS of $-0.24, diluted EPS of $-0.24, free cash flow per share of $-0.27, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 28.57% year-over-year and EPS growth of -30.15% year-over-year. On the balance sheet, it maintains a current ratio of 18.56x, a quick ratio of 17.63x, working capital of $68.28M, a debt-to-equity ratio of 0.06x, a debt ratio of 0.06, an interest coverage ratio of -8.54x, free cash flow of $-17.93M (TTM), and net debt of $-3.42M. Figures sourced from SEC EDGAR.
- Market Cap
- $130.97M
- P/E TTM
- -8.02x
- EPS TTM
- $-0.24
- P/B TTM
- 1.90x
- ROE TTM
- -32.91%
- ROA TTM
- -30.68%
- Debt To Equity
- 0.06x
- Free Cash Flow TTM
- $-17.93M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Microbot Medical Inc. in?
Microbot Medical Inc. (MBOT) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does MBOT trade on?
Microbot Medical Inc. (MBOT) trades on the Nasdaq.
Where is Microbot Medical Inc. incorporated?
Microbot Medical Inc. is incorporated in DE.
When was Microbot Medical Inc. (MBOT)'s most recent SEC filing?
Microbot Medical Inc. (MBOT)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is MBOT's market cap?
Microbot Medical Inc. (MBOT) has a market capitalization of $130.97M as of 2026-06-30.
What is MBOT's EPS (earnings per share)?
Microbot Medical Inc. (MBOT)'s trailing twelve month EPS is $-0.24 as of 2026-06-30.
What is MBOT's ROE (return on equity)?
Microbot Medical Inc. (MBOT)'s trailing twelve month Return on Equity (ROE) is -32.91% as of 2026-06-30.
What is MBOT's ROA (return on assets)?
Microbot Medical Inc. (MBOT)'s trailing twelve month Return on Assets (ROA) is -30.68% as of 2026-06-30.
What is MBOT's ROIC (return on invested capital)?
Microbot Medical Inc. (MBOT)'s trailing twelve month Return on Invested Capital (ROIC) is -40.35% as of 2026-06-30.
What is MBOT's EV/EBITDA?
Microbot Medical Inc. (MBOT)'s trailing twelve month EV/EBITDA is -6.91x as of 2026-06-30.